Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Liver Cirrhosis

  Free Subscription


Articles published in J Hepatol

Retrieve available abstracts of 184 articles:
HTML format
Text format



Single Articles


    January 2012
  1. SHAH N , Dhar D, Mohammed F, Habtesion A, et al
    Prevention of Acute Kidney Injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  2. BOONSTRA K , Beuers U, Ponsioen CY
    Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  3. PEREIRA G , Guevara M, Fagundes C, Sola E, et al
    Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  4. CUCCHETTI A , Trevisani F, Cescon M, Ercolani G, et al
    Cost-effectiveness of semiannual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  5. SHAWCROSS DL , Austin MJ, Abeles RD, McPhail MJ, et al
    The Impact of Organ Dysfunction in Cirrhosis: Survival at a Cost?
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  6. RODRIGUEZ-VILARRUPLA A , Lavina B, Garcia-Caldero H, Russo L, et al
    PPARalpha Activation Improves Endothelial Dysfunction And Reduces Fibrosis And Portal Pressure In Cirrhotic Rats.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available



  7. MERLI M , Lucidi C
    Bacterial resistance in cirrhotic patients: an Emerging reality.
    J Hepatol. 2012.
    PubMed     Text format     Related articles   



    December 2011
  8. LEDINGHEN VD , Wong VW, Vergniol J, Wong GL, et al
    Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan(R)
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  9. SALMON D , Bani-Sadr F, Loko MA, Stitou H, et al
    Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-coinfected patients: Results from ANRS CO13 HEPAVIH.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  10. FEDE G , D'Amico G, Arvaniti V, Tsochatzis E, et al
    Renal failure and cirrhosis: a systematic review of mortality and prognosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  11. NISCHALKE HD , Berger C, Luda C, Muller T, et al
    The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian Patients.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  12. TRITTO G , Mookerjee RP, Jalan R
    Reply to: The quest for the elusive factors that underpin neutrophil dysfunction in cirrhosis goes on.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  13. VIJAY GK , Taylor NJ, Shawcross DL
    The quest for the elusive factors that underpin neutrophil dysfunction in cirrhosis goes on.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



    October 2011
  14. CARDENAS A , Gines P, Marotta P, Czerwiec F, et al
    Tolvaptan, an Oral Vasopressin Antagonist, in the Treatment of Hyponatremia in Cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  15. LLEO A , Eric Gershwin M, Mantovani A, Invernizzi P, et al
    Towards Common Denominators in Primary Biliary Cirrhosis: The Role of IL-12.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  16. JONES DE
    A potential retroviral aetiology for mouse PBC: more answers or more questions?
    J Hepatol. 2011;55:750-2.
    PubMed     Text format     Related articles   



  17. ZHANG G , Chen M, Graham D, Subsin B, et al
    Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models.
    J Hepatol. 2011;55:876-84.
    PubMed     Text format     Related articles    Abstract available



  18. SOGA T , Sugimoto M, Honma M, Mori M, et al
    Serum metabolomics reveals gamma-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.
    J Hepatol. 2011;55:896-905.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  19. NAHON P , Sutton A, Rufat P, Charnaux N, et al
    A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  20. YOUSUF F , Yeoman AD
    Do fatigue and UDCA therapy truly have independent effects on mortality in PBC?
    J Hepatol. 2011;55:729.
    PubMed     Text format     Related articles   



  21. LIU Y , Wang Z, Kwong SQ, Lui EL, et al
    Inhibition of PDGF, TGF-beta, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib.
    J Hepatol. 2011;55:612-25.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  22. LEVESQUE E , Hoti E, Azoulay D, Ichai P, et al
    Prospective Evaluation of the Prognostic Scores for Cirrhotic Patients admitted to an Intensive Care Unit.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  23. LLOP E , Berzigotti A, Reig M, Erice E, et al
    Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumours.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  24. PINZANI M
    Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?
    J Hepatol. 2011;55:459-65.
    PubMed     Text format     Related articles    Abstract available



  25. DOGRU T , Genc H, Ercin CN, Tapan S, et al
    Non-invasive prediction of fibrosis in non-alcoholic fatty liver disease.
    J Hepatol. 2011;55:498-9.
    PubMed     Text format     Related articles   



  26. KRAWCZYK M , Grunhage F, Zimmer V, Lammert F, et al
    Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease.
    J Hepatol. 2011;55:299-306.
    PubMed     Text format     Related articles    Abstract available



  27. PATSENKER E , Schneider V, Ledermann M, Saegesser H, et al
    Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.
    J Hepatol. 2011;55:388-98.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  28. SCHLOSSER B , Stein A, Neuhaus R, Pahl S, et al
    Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  29. SINGH V , Dhungana SP, Singh B, Vijayverghia R, et al
    Midodrine In Patients With Cirrhosis And Refractory Or Recurrent Ascites: A Randomized Pilot Study.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  30. MUNTEANU M , Ratziu V, Poynard T
    FibroStic: a large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted.
    J Hepatol. 2011;55:233.
    PubMed     Text format     Related articles   



    June 2011
  31. VIOLI F , Basili S, Raparelli V, Chowdary P, et al
    Patients with Liver Cirrhosis Suffer from Primary Haemostatic Defects? Fact or Fiction?
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  32. THABUT D , Rudler M, Lebrec D
    Early TIPS with covered stents in high-risk patients with cirrhosis presenting with variceal bleeding: are we ready to dive into the deep end of the pool?
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  33. BEUERS U , Lindor KD
    A major step towards effective treatment evaluation in primary biliary cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



    May 2011
  34. N'KONTCHOU G , Aout M, Laurent A, Nahon P, et al
    Survival after Radiofrequency Ablation and Salvage Transplantation in Patients with Hepatocellular Carcinoma and Child-Pugh A Cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  35. CORPECHOT C , Gaouar F, Chretien Y, Johanet C, et al
    Smoking as an Independent Risk Factor of Liver Fibrosis in Primary Biliary Cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  36. FAUSTHER M , Dranoff JA
    New insights on the pathogenesis of biliary cirrhosis provided by studies in FXR knockout mice.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  37. POELSTRA K , Schuppan D
    Targeted therapy of liver fibrosis/cirrhosis and its complications.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  38. BUREAU C , Metivier S, D'Amico M, Peron JM, et al
    Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS.
    J Hepatol. 2011;54:901-7.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  39. SHOUVAL D
    Further evidence for the potential role of mTOR inhibitors in the prevention of post-transplantation hepatic fibrosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  40. GLENN TK , Honar H, Liu H, Ter Keurs HE, et al
    Role of Cardiac Myofilament Proteins Titin and Collagen in the Pathogenesis of Diastolic Dysfunction in Cirrhotic Rats.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  41. CORPECHOT C , Chazouilleres O, Poupon R
    Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  42. FOX AN , Terrault NA
    Individualizing hepatitis B infection prophylaxis in liver transplant recipients.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  43. SHOUVAL D
    Focus.
    J Hepatol. 2011;54:597-8.
    PubMed     Text format     Related articles   



  44. TSOCHATZIS EA , Gurusamy KS, Ntaoula S, Cholongitas E, et al
    Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy.
    J Hepatol. 2011;54:650-9.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  45. SENZOLO M , Patch D, Burra P, Burroughs AK, et al
    Tips for Portal Vein Thrombosis (PVT) in Cirrhosis: Not Only Unblocking a Pipe.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  46. ANGELI P
    beta-blockers and refractory ascites in cirrhosis: the message of a team of true scientists.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  47. MOOKERJEE RP , Lackner C, Stauber R, Stadlbauer V, et al
    The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  48. SUN H , Chen L, Zhou W, Hu L, et al
    The protective role of hydrogen-rich saline in experimental liver injury in mice.
    J Hepatol. 2011;54:471-80.
    PubMed     Text format     Related articles    Abstract available



  49. POYNARD T
    First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy.
    J Hepatol. 2011;54:586-7.
    PubMed     Text format     Related articles   



    February 2011
  50. NISCHALKE HD , Berger C, Aldenhoff K, Thyssen L, et al
    Toll-like receptor (TLR) 2 promotor and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  51. SERSTE T , Francoz C, Durand F, Rautou PE, et al
    Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  52. KIM MY , Cho MY, Baik SK, Park HJ, et al
    Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  53. EL-MAOUCHE D , Mehta SH, Sutcliffe C, Higgins Y, et al
    Controlled HIV Viral Replication, Not Liver Disease Severity Associated with Low Bone Mineral Density in HIV/HCV Co-Infection.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  54. TREPO E , Gustot T, Degre D, Lemmers A, et al
    Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  55. COANT N , Simon-Rudler M, Gustot T, Fasseu M, et al
    Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  56. WASMUTH HE , Trautwein C
    Prediction of fibrosis progression in hepatitis C infection: Are genetics ready for clinical use?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  57. SALVATORE P , Filippo M, Silvano F, Marta C, et al
    Continuous Recurrence of Type 1 Hepatorenal Syndrome and Long-Term Treatment with Terlipressin and Albumin: a New Exception to Meld Score in the Allocation System to Liver Transplantation?
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  58. TERRIER B , Carrat F, Geri G, Pol S, et al
    Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  59. MULLER T , Buch S, Berg T, Hampe J, et al
    Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  60. DULTZ G , Kronenberger B, Azizi A, Mihm U, et al
    Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  61. TRINCHET JC
    Surveillance for hepatocellular carcinoma in cirrhotic patients: from official recommendations to the real life.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



    January 2011
  62. BERZSENYI MD , Woollard DJ, McLean CA, Preiss S, et al
    Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  63. PALMERI ML , Wang MH, Rouze NC, Abdelmalek MF, et al
    Noninvasive Evaluation of Hepatic Fibrosis using Acoustic Radiation Force-Based Shear Stiffness in Patients with Nonalcoholic Fatty Liver Disease.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  64. LENCI I , Tisone G, Di Paolo D, Marcuccilli F, et al
    Safety of Complete and Sustained Prophylaxis Withdrawal in Patients Liver Transplanted for HBV-Related Cirrhosis at Low Risk of HBV Recurrence.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  65. WONG GL , Wong VW, Chan HL
    Is transient elastography inaccurate in chronic hepatitis B and non-alcoholic fatty liver disease?
    J Hepatol. 2011.
    PubMed     Text format     Related articles   



  66. TRITTO G , Bechlis Z, Stadlbauer V, Davies N, et al
    Evidence of Neutrophil Functional Defect Despite Inflammation in Stable Cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available



  67. RUFFILLO G , Fassio E, Alvarez E, Landeira G, et al
    Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease.
    J Hepatol. 2011;54:160-3.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  68. MA X , Xu L, Wang S, Cui B, et al
    Deletion of Steroid receptor coactivator-3 gene ameliorates hepatic steatosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  69. WANG X , Ikejima K, Kon K, Arai K, et al
    Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  70. BERZIGOTTI A , Nicolau C, Bellot P, Abraldes JG, et al
    Evaluation of Regional Hepatic Perfusion (RHP) by Contrast-ENHANCED Ultrasound in Patients with Cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  71. GUEVARA M , Baccaro ME, Gomez-Anson B, Frisoni G, et al
    Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  72. MASON AL
    The evidence supports a viral aetiology for primary biliary cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  73. LANGE CM , Moradpour D, Doehring A, Lehr HA, et al
    Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  74. SELMI C
    The evidence does not support a viral etiology for primary biliary cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  75. ASSY N
    Sub clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: A randomized controlled study Journal of Hepatology JHEPAT-D-10-00373R3.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  76. PRADELLA P , Bonetto S, Turchetto S, Uxa L, et al
    Platelet production and destruction in liver cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  77. MARDINI H , Smith FE, Record CO, Blamire AM, et al
    Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  78. PRAVEEN S , Shweta S, Chander SB
    Propofol in patients with cirrhosis and minimal hepatic encephalopathy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  79. SHAWCROSS DL , Sharifi Y, Canavan JB, Yeoman AD, et al
    Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  80. LAHARIE D , Seneschal J, Schaeverbeke T, Doutre MS, et al
    Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study.
    J Hepatol. 2010;53:1035-40.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  81. TREPO E , Potthoff A, Pradat P, Bakshi R, et al
    Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  82. PIANA G , Trinquart L, Meskine N, Barrau V, et al
    New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  83. KUANG DM , Zhao Q, Wu Y, Peng C, et al
    Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  84. LIN HC , Yang YY, Tsai TH, Huang CM, et al
    The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  85. RIPOLL C , Yotti R, Bermejo J, Banares R, et al
    The heart in liver transplantation.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  86. FRACANZANI AL , Valenti L, Bugianesi E, Vanni E, et al
    Risk of non alcoholic steatohepatitis and fibrosis in patients with non alcoholic fatty liver disease and low visceral adiposity.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  87. MAURY E , Vergniol J, de Ledinghen V, Rigalleau V, et al
    Skin Autofluorescence is high in patients with cirrhosis - further arguing for the implication of Advanced Glycation End Products.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  88. ISHIKAWA S , Ikejima K, Yamagata H, Aoyama T, et al
    CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  89. VALENTI L , Canavesi E, Galmozzi E, Dongiovanni P, et al
    Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease.
    J Hepatol. 2010;53:927-33.
    PubMed     Text format     Related articles    Abstract available



  90. SHOUVAL D
    The impact of fatigue and treatment with ursodeoxycholic acid on the prognosis of primary biliary cirrhosis: an extended 9 year follow-up.
    J Hepatol. 2010;53:789.
    PubMed     Text format     Related articles   



    October 2010
  91. PARK S , Choi Y, Um SJ, Yoon SK, et al
    Oleuropein Attenuates Hepatic Steatosis Induced by High-Fat Diet in Mice.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  92. NOVO E , Busletta C, di Bonzo LV, Povero D, et al
    Intracellular Reactive Oxygen Species Are Required For Directional Migration Of Resident And Bone Marrow-Derived Hepatic Pro-Fibrogenic Cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  93. LI C , Zheng S, You H, Liu X, et al
    Sphingosine 1-Phosphate (S1P)/S1P Receptors Is Involved in Human Liver Fibrosis by Action on Hepatic Myofibroblasts Motility.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  94. IACOBINI C , Menini S, Ricci C, Fantauzzi CB, et al
    Galectin-3 ablation protects mice from diet-induced nonalcoholic steatohepatitis.Major scavenging role of galectin-3 in liver.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  95. MONTAGNESE S , Middleton B, Mani AR, Skene DJ, et al
    Changes in the 24-h plasma cortisol rhythm in patients with cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  96. GALBOIS A , Thabut D
    Adrenal insufficiency: Diagnosis in patients with liver cirrhosis is difficult.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  97. SHOUVAL D
    Focus.
    J Hepatol. 2010;53:591-2.
    PubMed     Text format     Related articles   



  98. FRAQUELLI M , Rigamonti C, Casazza G, Donato MF, et al
    Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  99. GARCIA-CALDERO H , Rodriguez-Vilarrupla A, Gracia-Sancho J, Divi M, et al
    Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  100. MIYOSHI H , Moriya K, Tsutsumi T, Shinzawa S, et al
    Pathogenesis of lipid metabolism disorder in hepatitis C: Polyunsaturated fatty acids counteract lipid alterations induced by the core protein.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  101. KHALILI K , Kim TK, Jang HJ, Haider MA, et al
    Optimization of imaging diagnosis of 1-2cm hepatocellular carcinoma: An analysis of diagnostic performance and resource utilization.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  102. WENG SY , Yang CY, Li CC, Sun TP, et al
    Synergism between p53 and Mcl-1 in protecting from hepatic injury, fibrosis and cancer.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  103. ZEIN CO , Unalp A, Colvin R, Liu YC, et al
    Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  104. FABRIS C , Falleti E, Cussigh A, Bitetto D, et al
    IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  105. SHIMADA H , Staten NR, Rajagopalan LE
    TGF-beta1 mediated activation of Rho kinase induces TGF-beta2 and endothelin-1 expression in human hepatic stellate cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  106. SANDAHL TD , Jepsen P, Thomsen KL, Vilstrup H, et al
    Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: A nationwide population based cohort study.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  107. DI PASCOLI M , Zampieri F, Quarta S, Sacerdoti D, et al
    Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic rats.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  108. BOBERG KM , Chapman RW, Hirschfield GM, Lohse AW, et al
    Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  109. FEDE G , Spadaro L, Tomaselli T, Privitera G, et al
    Assessment of adrenocortical reserve in stable patients with cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  110. POYNARD T , Munteanu M, Colombo M, Bruix J, et al
    FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC(3) program.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  111. JALAN R , Olde Damink SW, Ter Steege JC, Redhead DN, et al
    Acute endotoxemia following transjugular intrahepatic stent-shunt insertion is associated with systemic and cerebral vasodilatation with increased whole body nitric oxide production in critically ill cirrhotic patients.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  112. COLECCHIA A , Scaioli E, Montrone L, Vestito A, et al
    Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  113. MENDLER MH , Agarwal A, Trimzi M, Madrigal E, et al
    A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method.
    J Hepatol. 2010;53:477-83.
    PubMed     Text format     Related articles    Abstract available



  114. CHEN YW , Liu BW, Zhang YJ, Chen YW, et al
    Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver.
    J Hepatol. 2010;53:528-36.
    PubMed     Text format     Related articles    Abstract available



  115. MEDICI V , Peerson JM, Stabler SP, French SW, et al
    Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease.
    J Hepatol. 2010;53:551-7.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  116. HAN G , Qi X, He C, Yin Z, et al
    Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  117. GARCIA-MONZON C , Lo Iacono O, Mayoral R, Gonzalez-Rodriguez A, et al
    Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  118. KHAMAYSI I , William N, Olga A, Alex I, et al
    Sub-clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: A randomized controlled study.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  119. GAIA S , Carenzi S, Barilli AL, Bugianesi E, et al
    Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  120. DEGOS F , Perez P, Roche B, Mahmoudi A, et al
    Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study).
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  121. SOLA E , Gines P
    Renal and circulatory dysfunction in cirrhosis: Current management and future perspectives.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  122. THABUT D , D'Amico G, Tan P, De Franchis R, et al
    Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: Analysis of the F7 liver-1288 study population.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  123. MCDONALD C , Newton J, Lai HM, Baker SN, et al
    Central nervous system dysfunction in primary biliary cirrhosis and its relationship to symptoms.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  124. CHEN Y , Johansson E, Yang Y, Miller ML, et al
    Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  125. FERNANDEZ-VARO G , Melgar-Lesmes P, Casals G, Pauta M, et al
    Inactivation of extrahepatic vascular Akt improves systemic hemodynamics and sodium excretion in cirrhotic rats.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  126. JONES DE , Al-Rifai A, Frith J, Patanwala I, et al
    The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: Results of a 9year follow-up.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  127. SALERNO F , Cazzaniga M, Accordino S
    May vaptans contribute to the treatment of refractory ascites?
    J Hepatol. 2010;53:225-7.
    PubMed     Text format     Related articles   



  128. RATZIU V
    Serum fibrosis markers: death by validation or a leap of faith?
    J Hepatol. 2010;53:222-4.
    PubMed     Text format     Related articles   



    July 2010
  129. NIRO GA , Smedile A, Ippolito AM, Ciancio A, et al
    Outcome of chronic delta hepatitis in Italy: A long-term cohort study.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  130. BERNARDI M , Santi L
    Renal sodium retention in pre-ascitic cirrhosis: The more we know about the puzzle, the more it becomes intricate.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  131. SANSOE G , Aragno M, Tomasinelli CE, di Bonzo LV, et al
    Calcium-dependent diuretic system in preascitic liver cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  132. THABUT D , Shah V
    Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: New targets for the treatment of portal hypertension?
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  133. GUPTA A , Dhiman RK, Kumari S, Rana S, et al
    Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  134. NKONTCHOU G , Bastard JP, Ziol M, Aout M, et al
    Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  135. GOETZ M , Deris I, Vieth M, Murr E, et al
    Near-infrared confocal imaging during mini-laparoscopy: a novel rigid endomicroscope with increased imaging plane depth.
    J Hepatol. 2010;53:84-90.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  136. TREBICKA J , Hennenberg M, Odenthal M, Shir K, et al
    Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  137. CHENG WS , Roberts SK, McCaughan G, Sievert W, et al
    Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  138. SEBASTIANI G , Tempesta D, Fattovich G, Castera L, et al
    Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  139. ALTORJAY I , Vitalis Z, Tornai I, Palatka K, et al
    Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available




  140. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  141. NAVEAU S , Cassard-Doulcier AM, Njike-Nakseu M, Bouchet-Delbos L, et al
    Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease.
    J Hepatol. 2010;52:895-902.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  142. SETO WK , Lai CL, Fung J, Hung I, et al
    Natural history of chronic hepatitis C: Genotype 1 versus genotype 6.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  143. JOSHITA S , Umemura T, Yoshizawa K, Katsuyama Y, et al
    Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  144. WONG F , Gines P, Watson H, Horsmans Y, et al
    Effects of a selective vasopressin V(2) receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  145. JOHN-BAPTISTE A , Krahn M, Heathcote J, Laporte A, et al
    The natural history of hepatitis C infection acquired through injection drug use: Meta-analysis and meta-regression.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  146. SASAKI M , Miyakoshi M, Sato Y, Nakanuma Y, et al
    Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  147. RIGGIO O , Ridola L, Angeloni S, Cerini F, et al
    Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: Results of a randomized controlled trial.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  148. SANTI V , Trevisani F, Gramenzi A, Grignaschi A, et al
    Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  149. HOARE M , Gelson WT, Das A, Fletcher JM, et al
    CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  150. CALES P , Halfon P, Batisse D, Carrat F, et al
    Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  151. WANG Y , Gao J, Zhang D, Zhang J, et al
    New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  152. EUN JR , Lee HJ, Kim TN, Lee KS, et al
    Risk assessment for the development of hepatocellular carcinoma: According to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  153. LIM YS , Larson TS, Benson JT, Kamath PS, et al
    Serum sodium, renal function, and survival of patients with end-stage liver disease.
    J Hepatol. 2010;52:523-8.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  154. MOLLER S , Henriksen JH
    Cirrhotic cardiomyopathy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  155. HOLLINGSWORTH KG , Newton JL, Robinson L, Taylor R, et al
    Loss of capacity to recover from acidosis in repeat exercise is strongly associated with fatigue in primary biliary cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  156. CORPECHOT C , Chretien Y, Chazouilleres O, Poupon R, et al
    Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  157. CHOLONGITAS E , Xirouchakis E, Garcovich M, Burroughs AK, et al
    Evaluation of renal function in patients with cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  158. SHINDO N , Fujisawa T, Sugimoto K, Nojima K, et al
    Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  159. CASTERA L
    Diagnosing cirrhosis non-invasively: Sense the stiffness but don't forget the nodules!
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  160. MANN DA , Marra F
    Fibrogenic signalling in hepatic stellate cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  161. GALBOIS A , Rudler M, Massard J, Fulla Y, et al
    Assessment of adrenal function in cirrhotic patients: Salivary cortisol should be preferred.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  162. BERZIGOTTI A , Abraldes JG, Tandon P, Erice E, et al
    Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  163. GENNINGS C , Heuman D, Fulton O, Sanyal AJ, et al
    Use of desirability functions to evaluate health status in patients with cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  164. HOV JR , Lleo A, Selmi C, Woldseth B, et al
    Genetic associations in Italian primary sclerosing cholangitis: Heterogeneity across Europe defines a critical role for HLA-C.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  165. GAILHOUSTE L , Le Grand Y, Odin C, Guyader D, et al
    Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis.
    J Hepatol. 2010;52:398-406.
    PubMed     Text format     Related articles    Abstract available



  166. BEDOSSA P
    Harmony in liver fibrosis...
    J Hepatol. 2010;52:313-4.
    PubMed     Text format     Related articles   



    February 2010
  167. POUPON R
    Primary biliary cirrhosis: A 2010 update.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  168. FORNS X , Bruix J
    Treating hepatitis C in patients with cirrhosis: The effort is worth it.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   



  169. HERINGLAKE S , Hofdmann M, Fiebeler A, Manns MP, et al
    Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.
    J Hepatol. 2010;52:220-7.
    PubMed     Text format     Related articles    Abstract available



  170. MILLONIG G , Friedrich S, Adolf S, Fonouni H, et al
    Liver stiffness is directly influenced by central venous pressure.
    J Hepatol. 2010;52:206-10.
    PubMed     Text format     Related articles    Abstract available



    January 2010
  171. FRANCOZ C , Glotz D, Moreau R, Durand F, et al
    The evaluation of renal function and disease in patients with cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available



  172. FRITH J , Day CP, Robinson L, Elliott C, et al
    Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease.
    J Hepatol. 2010;52:112-6.
    PubMed     Text format     Related articles    Abstract available



    December 2009
  173. TAURA P , Fuster J, Mercadal J, Martinez-Palli G, et al
    The use of beta-adrenergic drugs improves hepatic oxygen metabolism in cirrhotic patients undergoing liver resection.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available



  174. LISMAN T , Bakhtiari K, Pereboom IT, Hendriks HG, et al
    Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available



  175. CLAASSEN MA , de Knegt RJ, Tilanus HW, Janssen HL, et al
    Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available



  176. DAI CY , Ho CK, Huang JF, Hsieh MY, et al
    Hepatitis C virus viremia and low platelet count: A study in a hepatitis B & C endemic area in Taiwan.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available



  177. SHERMAN M
    Vinyl chloride and the liver.
    J Hepatol. 2009;51:1074-81.
    PubMed     Text format     Related articles    Abstract available



    November 2009
  178. CASTERA L , Sebastiani G, Le Bail B, de Ledinghen V, et al
    Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available



  179. PAPATHEODORIDIS GV , Chrysanthos N, Cholongitas E, Pavlou E, et al
    Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.
    J Hepatol. 2009;51:931-8.
    PubMed     Text format     Related articles    Abstract available



    October 2009
  180. KAO YH , Chen CL, Jawan B, Chung YH, et al
    Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available



    September 2009
  181. SAMRI A , Roque-Afonso AM, Beran O, Tateo M, et al
    Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available



  182. MALIK R , Mookerjee RP, Jalan R
    Infection and inflammation in liver failure: two sides of the same coin.
    J Hepatol. 2009;51:426-9.
    PubMed     Text format     Related articles   



  183. NOZAKI Y , Fujita K, Yoneda M, Wada K, et al
    Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease.
    J Hepatol. 2009;51:548-56.
    PubMed     Text format     Related articles    Abstract available



    August 2009
  184. DE NICOLA S , Aghemo A, Rumi MG, Colombo M, et al
    HCV genotype 3: An independent predictor of fibrosis progression in chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: